Evidence map›Paper›PMID 41705045›Full record

ArticleFrontiers in public health2026

Every prescription counts: rethinking outpatient antibiotic stewardship in Abu Dhabi, United Arab Emirates.

Kanika Vats, Samar Alnasir, Rahaf Ajaj

Abstract read
In one paragraph

Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Kanika VatsDirectorate of Research and Innovation, TASNEEF (Emirates Classification Society), Abu Dhabi, United Arab Emirates.
Samar AlnasirDepartment of Pharmacy, Medeor 24x7 Hospital, Abu Dhabi, United Arab Emirates.
Rahaf AjajDepartment of Environmental Health and Safety, Abu Dhabi University College of Health Sciences, Abu Dhabi, United Arab Emirates.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antimicrobial resistance (AMR) is a persistent global health challenge that is associated with morbidity, mortality, and healthcare costs. In most outpatient (OP) settings, such as emergency rooms, primary and specialty care clinics, and dental clinics, antibiotics are often inaccurately prescribed due to patient expectations, empirical decision-making, and limited access to diagnostic data. Despite existing national frameworks, surveillance systems, and stewardship initiatives, resistance among key pathogens in the United Arab Emirates (UAE), a part of the World Health Organization's (WHO's) Eastern Mediterranean Region (EMR), is increasing. Many OP settings are underdeveloped, as most efforts focus on hospital inpatients, leading to inappropriate antibiotic use, the promotion of resistant pathogens, and an increased risk of community-acquired infections. Intensifying antimicrobial stewardship (AMS) practices in OP settings brings an opportunity to enhance patient care, limit unnecessary prescriptions, prevent adverse reactions, and reduce healthcare costs. This perspective provides insights into regional AMR trends in the EMR, reviews existing governance, regulatory frameworks, and surveillance systems of the UAE, and identifies gaps with OP stewardship practices in the Emirate of Abu Dhabi. It recommends a multi-level framework to support optimisation of OP antibiotic use, guided by regional trends, current practice, and lessons learnt from the COVID-19 pandemic. By adopting this framework, current stewardship efforts can be strengthened, responsible antibiotic use promoted, and surveillance improved, progressing towards a coordinated, multi-sector strategy to preserve antimicrobial efficacy and sustain long-term progress against resistance.

Indexed as

Ambulatory CareAnti-Bacterial AgentsAntimicrobial StewardshipOutpatientsHumansUnited Arab EmiratesAnti-Bacterial Agentsantibioticantibiotic stewardship program (ASP)antimicrobial resistance (AMR)clinical outcomesEastern Mediterranean region (EMR)outpatient settingssurveillanceUnited Arab Emirates (UAE)

Identifiers

PMID41705045
PMCPMC12907433

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.